无观察效应度 (NOEC) 和最大半有效度 (EC50) 的模型
Nadia Iovine1, Alla P Toropova1, Andrey A Toropov1
1Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Via Mario Negri 2, 20156 Milan, Italy.
Toxics
|June 26, 2024
概括
这项研究引入了新的in silico生态毒理学模型,用于预测对虫和虫的影响. 这些模型增强了预测多样性,为环境风险评估提供了有价值的工具.
科学领域:
- 环境毒理学环境毒理学
- 计算化学是一种计算化学.
- 生态毒理学 生态毒理学
背景情况:
- 目前的in silico生态毒理学模型缺乏终点多样性.
- 在环境风险评估中需要更广泛的预测能力.
研究的目的:
- 开发新的 in silico 模型来预测生态毒理学终点.
- 为*Chironomus riparius*和*Lemna gibba*的EC50建立没有观察到效应度 (NOEC) 的模型.
主要方法:
- 使用了来自EFSA OpenFoodTox数据库的数据.
- 开发了基于CORAL软件的2D描述器的定量结构-活动关系 (QSAR) 模型.
- 采用蒙特卡洛方法来确定算法相关性权重.
主要成果:
- 在外部验证中,NOAEC (鸟) 的确定系数为0.74,EC50 (子) 的确定系数为0.85.
- 成功模拟了两个不同的物种的特定生态毒理学终点.
结论:
- 开发的模型代表了增加生态毒理学终点多样性的新方法.
- 这些模型显示出NOEC和EC50值的良好预测性能,支持它们在风险评估中的使用.
相关概念视频
Drug Concentration Versus Time Correlation
721
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
721
Time Course of Drug Effect
2.0K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.0K
Pharmacokinetic Models: Comparison and Selection Criterion
66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
456
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
456
Nonlinear Pharmacokinetics: Michaelis-Menten Equation
310
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
310
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
57
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
57


